The S&P/TSX Capped Health Care Index is up 6.26% month to date and has gained 44.68% this year, outperforming the benchmark S&P/TSX Venture Composite which is down 3.88% year to date and the S&P/TSX 60 Capped Index that has lost 4.10%.
The Health Care Index consists of all members of the S&P/TSX Venture Composite that are classified within the GICS® health care sector and its constituents include:
- Aphria Inc. (APH)
- Aurora Cannabis Inc. (ACB)
- Baush Health Companies (BHC)
- Canopy Growth Corp. (WEED)
- Chartwell Retirement Residences (CSH.UN)
- Extendicare Inc. (EXE)
- Knight Therapeutics Inc. (GUD)
- Sienna Senior Living Inc. (SIA)
Yesterday, Aurora Cannabis Inc. (ACB) declined more than 7%, Canopy Growth Corporation (WEED) closed the day down 6.85% and Aphria Inc. (APH) ended down around 6%. Extendicare (EXE), Knight Therapeutics Inc. (GUD) and Bausch Health Companies Inc. (BHC) all recorded strong gains.
As the healthcare sector continues to outperform the broad market, investors are looking fresh opportunities within the sector. Here are 3 Canadian healthcare stocks that seem to be following the lastest industry trend.
Premier Health Group, Inc. (PHGI) is developing innovative health care approaches that combine human skill-based expertise with emerging technologies. Premier Health’s subsidiary, HealthVue is focused on developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence (AI).
Premier Health is currently reviewing a pipeline of strategic acquisitions and scouting new locations, with the expectation to close on two of these opportunities in Q4-2018. The company is specifically targeting acquisitions of clinics, technology and patients in addition to cannabis clinic(s) and partnerships.
The company recently announced selecting Reliq Health Technologies Inc. (RHT) as its exclusive technology partner. Reliq will be providing Premier’s HealthVue primary care clinics with a HealthVue-branded telemedicine, remote monitoring & AI solution for its clinical staff and 100,000 active patients.
FSD Pharma Inc. (HUGE) operates as a cannabis company involved in hydroponic indoor cannabis production and processing activities through its subsidiary, FV Pharma Inc., which holds production license to under the ACMPR. In regard to R&D, the company has an alliance with SciCann Therapeutics, which develops novel cannabis-based pharmaceutical products and has an exclusive license in Canada for the production of a line of proprietary cannabinoid-based, patent-pending, indication-specific products.
FSD has several joint ventures with companies including: Auxly Cannabis Group Inc., for a contribution towards 220,000 sq. ft. of cultivation, R&D, genetics, and extraction capabilities, Canntab Therapeutics Ltd., where FSD provides up to 10,000 sq. ft. of space at its Cobourg facility for development of cannabis oral delivery platforms, and High Tide Ventures, owner of brands RGR Canada Inc., Smokers Corner, Canna Cabana, and soon, Famous Brandz.
Biotech Breakroom is an affiliate of Midam Ventures LLC. Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. MIDAM was hired for a period from 10/1/2018 – 4/1/2018 to publicly disseminate information about Premier Health Group Inc. Midam was paid $100,000 (CASH) & “500,000” shares of restricted common shares, they own zero shares that were purchased in the open market. Once the (6) six-month restriction is complete on 4/1/2018, Midam plans to sell the “500,000” shares of Premier Health Group Inc. that they hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Midam may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full Midam disclaimer.